Научно обоснованные перспективы профилактического приема витамина D


А.С. Михайлова, А.Г. Закроева, А.Д. Сахнин

ФГБОУ ВО УГМУ Минздрава России, Екатеринбург
В данном обзоре рассматриваются физиологические и функциональные особенности витамина D и его основных метаболитов, пути их синтеза и активации, точки приложения и главные клинические эффекты. Отдельное внимание уделено анализу доступных публикаций, посвященных оценке влияния витамина D в отношении профилактики развития и прогрессирования нарушений костного метаболизма, аутоиммунных и онкологических заболеваний, болезней сердечно-сосудистой, нервной и репродуктивной систем.

Литература


1. Glenville J., Strugnell S.A., DeLuca H.F. Current Understanding of the Molecular Actions of Vitamin D. Physiological Rev. 1998;78(4):1193–231.

2. Kimmel-Jehan C., Darwish H.M., Strugnell S.A., Jehan F., Wiefling B., DeLuca H.F. DNA binding is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. J. Cell Biochem. 1999;74:220–28.

3. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., Kovacs C.S., Mayne S.T., Rosen C.J., Shapses S.A. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrin. Metab. 2011;96:53–8.

4. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrin. Metab. 2011;96:1911–30.

5. Tucker G., Gagnon R.E., Haussler M.R. Vitamin D3-25-hydroxylase: tissue occurrence and lack of regulation. Archives of Biochemistry and. Biophysics.1997;155:47–57.

6. Suda T., Ueno Y., Fujii K., Shinki T. Vitamin D and bone. J. Cell Biochem. 2002;88:259–66.

7. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004;80(Suppl. 6):1689–96.

8. Hypponen E., Laara E., Reunanen A., Järvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2014;358:1500–503.

9. Multiple Sclerosis Society Scotland. Shine on Scotland campaign Article, 24. April 2011.

10. Bhalla A.K. Amento E.P., Clemens T.L., Holick M.F., Krane S.M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrin. Metab. 1983;57:1308–10.

11. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academic of Sciences in USA. 1996;93:7861–64.

12. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J. Am. Med. Association. 2006;296:2832–38.

13. Zella J.B., DeLuca H.F. Vitamin D and autoimmune diabetes. J. Cell Biochem. 2003;88:216–22.

14. Lemire J.M., Ince A., Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity. 1992;12:143–48.

15. Nicholson A., Dalzell M., El-Matary W. Vitamin D as a therapy for colitis: A systematic review. J. Crohn’s and Colitis. 2012;6(4):405–11.

16. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutrition. 1998;128:68–72.

17. Kalueff A.V., Minasyan A., Keisala T, Kuuslahti M., Miettinen S., Tuohimaa P. The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS and Neurological Disorders-Drug Targets. 2006;5(3):363–71.

18. Kerr D.R., Zava D.T., Piper W.T., Saturn S.R., Frei B., Gombart A.F. Associations between Vitamin D Levels and Depressive Symptoms in Healthy Young Adult Women. Psych. Res. 2015;227(1):46–51.

19. Eyles D.W., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanatomy. 2005;29(1):21–30.

20. Kunzmann A.T., Cantwell M.M., Murray, L.J., Ng K., Carroll, D., Coleman, H.G. Vitamin D, Vitamin D Receptor Expression, Vitamin D-Related Gene Variants and Colorectal Cancer Progression. Syst. Rev. Nutrients. 2014;6(7):2759–919.

21. Yao S., Kwan M.L., Ergas I.J., Roh J.M., Cheng T.D., Hong C.C., McCann S.E., Tang L., Davis W., Liu S., Quesenberry C.P. Jr, Lee M.M., Ambrosone C.B., Kushi L.H. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. J. Am. Med. Association. Oncology. 2017;3(3):351–57.

22. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Krstic G., Wetterslev J., Gluud C. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst. Rev. 2014;(6):CD007469.

23. Zittermann A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2012;95(1):91–100.

24. Michaëlsson K., Baron J.A., Snellman G., Gedeborg R., Byberg L., Sundström J., Berglund L., Arnlöv J., Hellman P., Blomhoff R., Wolk A., Garmo H., Holmberg L., Melhus H. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 2010;92:841–48.

25. Мelamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Int. Med. 2008;168:1629–37.

26. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., Simonetti R.G., Bjelakovic M., Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 2014;(1):CD007470.

27. McKenna M.J., Murray B.F., O’Keane M., Kilbane M.T. Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future. Endocrine Connections. 2015;4(3):163–71.

28. Hossein-nezhad A., Holick M.F. Vitamin D for Health: A Global Perspective. Mayo Clin. Proceed. 2013;88(7):720–55.

29. Liu L., Chen M., Hankins S.R., Nùñez A.E., Watson R.A., Weinstock P.J., Newschaffer C.J., Eisen H.J. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am. J. Cardiol. 2012;110(6):834–39.

30. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 2004;1–5:89–90, 387–92.

31. Burgaz A., Orsini N., Larsson S.C., Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J. Hypertension. 2011;29(4):636–45.

32. Pittas A.G., Chung M., Trikalinos T., Mitri J., Brendel M., Patel K., Lichtenstein A.H., Lau J., Balk E.M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann. Int. Med. 2010;152(5):307–14.

33. Pillai S., Bikle D.D. Role of intracellular free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D. J. Cell Physiol. 1991;146:94–100.

34. Dokoh S., Donaldson C.A., Marion S.L., Pike J.W., Haussler M.R. The ovary: a target organ for 1,25-dihydroxyvitamin D3. Endocrinol. 1983;112:200–6.

35.Kaludjerovic J., Vieth R., Midwifery J. Relationship between vitamin D during perinatal development and health. Womens Health. 2010;55(6):550–60.

36. Holick M.F. Nutrition: D-iabetes and D-eath D-efying vitamin D. National Rev. Endocrinol. 2012;8(7):388–90.

37. Lucas R.M., Ponsonby A.L., Pasco J.A., Morley R. Future health implications of prenatal and early-life vitamin D status. Nutr. Rev. 2008;66(12):710–20.

38. Kim B.G., Chang S.K., Kim S.M., Hwang J.S., Jung J.W. Dilated cardiomyopathy in a 2 month-old infant: a severe form of hypocalcemia with vitamin d deficient rickets. Korean Circ. J. 2010;40(4):201–3.

39. Maka N., Makrakis J., Parkington H.C., Tare M., Morley R., Black M.J. Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Ped. Nephrol. 2008;23(1):55–61.

40. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience. 2003;118(3):641–53.


Об авторах / Для корреспонденции


Автор для связи: А.С. Михайлова – к.м.н., ассистент кафедры профилактической и семейной медицины, ФГБОУ ВО УГМУ Минздрава России, Екатеринбург; тел. 8 (343) 214-87-98; e-mail: mikhaylovamail@ya.ru


Похожие статьи


Бионика Медиа